Product Information
DROXIDOPA 300 MG CAPSULE is a generic product labeled by CivicaScript LLC, priced at $2.1456 per EA under NDC 82249055490. Its NADAC has been published 63 times since Jun 11, 2025.
FDA first approved this application on Feb 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
CivicaScript LLCNDC
82249055490
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA213911FDA Approved
2/18/2021
TE Code
AB
On Market Since
3/3/2025
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 300 MG CAPSULE has been published 63 times since Jun 11, 2025, and over the history we have for it it has declined 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1456 per EA |
|---|---|
| All-time high | $2.8151 (Jun 10, 2026) |
| All-time low | $2.1456 (Aug 19, 2026) |
| 52-week high | $2.8151 |
| 52-week low | $2.1456 |
| Median price | $2.4549 |
| Average price | $2.4945 |
| Largest weekly change | -11.4% (Jul 22, 2026) |
| Weeks tracked | 63 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROXIDOPA 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 300 MG CAPSULE, manufactured by CivicaScript LLC, is $2.1456 per EA (NDC 82249055490), effective Aug 19, 2026.
How has the price of DROXIDOPA 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 300 MG CAPSULE has declined 5.5%. It has been tracked across 63 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 300 MG CAPSULE?
Since Jun 11, 2025, the NADAC for DROXIDOPA 300 MG CAPSULE has ranged from a low of $2.1456 (Aug 19, 2026) to a high of $2.8151 (Jun 10, 2026), with a median of $2.4549 per EA.
Are there cheaper alternatives to DROXIDOPA 300 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DROXIDOPA 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures DROXIDOPA 300 MG CAPSULE?
DROXIDOPA 300 MG CAPSULE (NDC 82249055490) is labeled by CivicaScript LLC, and CMS classifies it as a generic product.